|
|||||
|
|
Red blood cell in vitro quality and function is maintained after S‐303 pathogen inactivation treatment |
|
| Authors: | Kelly M. Winter Lacey Johnson Matthew Kwok Diana Vidovic Ryan A. Hyland Nina Mufti Anna Erickson Denese C. Marks |
| Affiliation: | 1. Research and Development, Australian Red Cross Blood Service, , Sydney, NSW, Australia;2. Cerus Corporation, , Concord, California |
| Abstract: | |
| Keywords: | |